Vaccines

15 Jul 2020 Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273)
15 Jul 2020 Zydus starts human dosing of its vaccine ‘ZyCoV-D’
14 Jul 2020 Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA
14 Jul 2020 Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate
14 Jul 2020 IMV Updates Rapid Progress on COVID-19 Vaccine Program
13 Jul 2020 Altimmune and the University of Alabama at Birmingham (UAB) Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID™
13 Jul 2020 Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19
13 Jul 2020 Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
08 Jul 2020 CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate
08 Jul 2020 Novavax Announces $1.6 Billion Funding from Operation Warp Speed
07 Jul 2020 GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
07 Jul 2020 Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial
02 Jul 2020 Sorrento Announces Selection of T-VIVA-19™ as Targeted Protein Vaccine Candidate for SARS-CoV-2
01 Jul 2020 Johnson & Johnson Announces European Commission Approval for Janssen’s Preventive Ebola Vaccine
01 Jul 2020 Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
30 Jun 2020 Meissa Vaccines Provides a Pipeline Update on Vaccine Candidates for COVID-19 and RSV
30 Jun 2020 INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19
26 Jun 2020 Entos Pharmaceuticals Announces Selection of Lead DNA Vaccine Candidates for COVID-19 and a $4.2M Award to Move Forward with Phase I/II Human Trials
26 Jun 2020 ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP
25 Jun 2020 Sinovac Receives Approval from China for its Quadrivalent Influenza Vaccine
24 Jun 2020 Immunovative Therapies and Mirror Biologics Announce US FDA Clearance of a Universal Anti-Viral Vaccine Phase I/II Clinical Trial for Healthy Elderly Adults
23 Jun 2020 Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
23 Jun 2020 First Participant Dosed in Phase 1 Clinical Study with VTP-300 Immunotherapeutic to Treat Chronically Infected Hepatitis B Patients
23 Jun 2020 Collaborative COVID-19 Vaccine Project Between ImmunoPrecise Antibodies Europe and LiteVax BV, Funded Through TRANSVAC2
22 Jun 2020 Merck Announces That V114, Its Investigational 15-valent Pneumococcal Conjugate Vaccine, Met Safety and Immunogenicity Objectives in Initial Phase 3 Studies in Adults

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top